SAN DIEGO – Past research has shown that patients with HIV infection vaccinated early in the flu season are generally more likely to contract influenza or influenza-like illness (ILI), compared with those receiving late vaccination. The reason likely is that… Read More
ANN ARBOR, MI — Oral pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) gained Food and Drug Administration approval in 2012, and many commentators hailed the therapy as a “once-in-a-generation” advance.
HOUSTON — After a decade of dramatically rising rates of hepatocellular carcinoma (HCC) among veterans, aggressive treatment of hepatitis C infections (HCV) appears poised to turn the tide.
SEATTLE — Pulmonary infections remain more common in patients with human immunodeficiency virus (HIV), compared with those who are uninfected. Surmising that an increase in chronic lung diseases among aging HIV positive patients could contribute to the risk, a University… Read More
Pre-infection Immunological Health Achieved in Some Cases By Annette M. Boyle SAN ANTONIO — For years, clinicians have not recommended treating human immunodeficiency virus (HIV) patients with antiretroviral therapy (ART) before they saw a significant drop in T-cell levels. Starting… Read More
Subhead: Post-operative Mortality Rates Low Among ART Users By Annette M. Boyle WEST HAVEN, CT — Historically, high post-operative mortality rates among HIV-infected patients caused many physicians and patients to defer or avoid surgery all together. For today’s veterans with… Read More
Raymond Schinazi, PhD, Hon DSc, still remembers how the patients lined the corridors. They were all too thin, too pale and much too weak.
Amid all the outcry over the high cost of new hepatitis C therapies, including congressional hearings, a simple fact has been overlooked: The VA expects to save money in the long run because of the drugs’ high cure rates. By… Read More
Alliance Research Not Limited by Private-Sector Restraints By Annette M. Boyle BETHESDA, MD – In celebration of its second anniversary, the John P. Murtha Cancer Center at the Walter Reed National Military Medical Center, announced plans to substantially expand its… Read More
VA Suggests High Price Could Be Offset Future Savings
By Brenda L. Mooney BOSTON – Rates of serologic testing for hepatitis B (HBV) at the VA fail to meet levels recommended by the American Association for the Study of Liver Diseases (AASLD) practice guideline, according to new research. Researchers… Read More
Clinicians Find Advances ‘Mind-Boggling’ By Annette M. Boyle ATLANTA – Therapeutic options for patients with human immunodeficiency virus (HIV) continue to expand, enabling more veterans to begin treatment with fewer adverse side effects and far less complicated regimens than even… Read More
By Annette M. Boyle WASHINGTON – While commercial insurers responded to the approval of the breakthrough drug sofosbuvir for hepatitis C (HCV) by implementing prescribing restrictions, limiting use to the sickest patients and charging higher co-pays because of the drug’s… Read More
BOSTON – Patients with disfiguring and debilitating scars suffer poor cosmetic outcomes, restricted motion, pain and itching, despite traditional therapy such as expert wound care. A consensus report published earlier this year in JAMA Dermatology discusses a breakthrough within the… Read More
We fear things in proportion to our ignorance of them. Christian Nestell Bovee (1820-1904) I had the honor of being invited recently to speak at the 39th annual Garland Lecture series at the Boston Medical Library. As I tend to… Read More
1964 S. Medicine publishes its first issue. The new Naval Station Hospital Saigon receives the first American combat casualties directly from the Vietnam War. 1965 A U.S. Marine Corps Hawk air defense missile battalion is deployed to Da Nang,… Read More
By Stephen Spotswood WASHINGTON – When the first Infectious Disease Clinic took place at the Washington, DC, VAMC in 1985, only a handful of HIV-infected patients took advantage. In fact, the disease hadn’t even been named “human immunodeficiency virus;” that… Read More
By Brenda L. Mooney PITTSBURGH – Will hepatitis C become a rare disease over the next two decades or so? The answer is yes, according to a computer simulation conducted by the University of Pittsburgh Graduate School of Public Health… Read More
DURHAM, NC – Poor adherence to antiretroviral therapy in veterans with human immunodeficiency virus (HIV) also is a good predictor of whether those same patients will achieve good control if they have diabetes. That’s according to a study from the… Read More